Segment Information

6 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Segment Information

(9) Segment Information

The Company has six reportable segments which include: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services, and Transportation. Information regarding the operations and assets of these reportable business segments is contained in the following table:

	Three months ended June 30,				Six months ended June 30,
Sale of Product	2017		2016		2017		2016
Radiochemical Products	$	558,817	$	400,948	$	1,172,397	$	783,193
Cobalt Products		84,643		191,869		304,066		505,655
Nuclear Medicine Standards		834,698		836,858		1,643,104		1,650,017
Radiological Services		302,534		233,080		495,333		361,067
Fluorine Products		-		-		-		-
Transportation		5,132		35,977		5,132		90,477
Total Segments		1,785,824		1,698,732		3,620,032		3,390,409
Corporate revenue		-		-		-		-
Total Consolidated	$	1,785,824	$	1,698,732	$	3,620,032	$	3,390,409
	Three months ended June 30,				Six months ended June 30,
Depreciation and Amortization	2017		2016		2017		2016
Radiochemical Products	$	1,609	$	1,750	$	3,218	$	3,498
Cobalt Products		9,084		14,000		18,854		23,691
Nuclear Medicine Standards		2,343		4,153		4,488		8,453
Radiological Services		9,886		8,755		19,434		15,716
Fluorine Products		30,751		28,012		56,846		55,960
Transportation		2,681		2,889		5,571		4,649
Total Segments		56,354		59,559		108,411		111,967
Corporate depreciation and amortization		(1,076)		1,599		2,452		3,199
Total Consolidated	$	55,278	$	61,158	$	110,863	$	115,166
	Three months ended June 30,				Six months ended June 30,
Segment Income (Loss)	2017		2016		2017		2016
Radiochemical Products	$	106,998	$	96,373	$	225,153	$	159,471
Cobalt Products		34,933		106,289		154,994		309,654
Nuclear Medicine Standards		195,661		207,069		379,633		361,800
Radiological Services		124,298		112,233		239,824		159,827
Fluorine Products		(56,157)		(121,119)		(141,035)		(195,300)
Transportation		(18,934)		(13,604)		(43,542)		(2,742)
Total Segments		386,799		387,241		815,027		792,710
Corporate loss		(988,994)		(832,669)		(2,203,490)		(1,612,655)
Net Loss	$	(602,195)	$	(445,427)	$	(1,388,463)	$	(819,945)
	Three months ended June 30,				Six months ended June 30,
Expenditures for Segment Assets	2017		2016		2017		2016
Radiochemical Products	$	-	$	-	$	-	$	-
Cobalt Products		-		-		-		-
Nuclear Medicine Standards		-		2,881		(198)		2,881
Radiological Services		10,040		36,010		10,040		40,813
Fluorine Products		6,030		-		10,202		8,719
Transportation		-		2,859		-		53,631
Total Segments		16,070		41,750		20,044		106,044
Corporate purchases		-		-		-		-
Total Consolidated	$	16,070	$	41,750	$	20,044	$	106,044
	June 30,		December 31,
Segment Assets	2017		2016
Radiochemical Products	$	275,907	$	267,920
Cobalt Products		1,681,160		1,414,240
Nuclear Medicine Standards		611,493		502,361
Radiological Services		160,274		171,354
Fluorine Products		5,754,983		5,801,627
Transportation		42,514		49,706
Total Segments		8,526,331		8,207,208
Corporate assets		3,273,274		3,172,057
Total Consolidated	$	11,799,605	$	11,379,265